We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

AcuSleep in Mild Traumatic Brain Injury (TBI) (AcuTBI)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01162317
First Posted: July 14, 2010
Last Update Posted: August 23, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
VA Office of Research and Development
June 15, 2010
July 14, 2010
November 14, 2016
April 5, 2017
August 23, 2017
July 5, 2011
September 30, 2015   (Final data collection date for primary outcome measure)
PSQI Change [ Time Frame: Baseline and post-intervention ]

change of global PSQI score as compared to baseline The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.

The PSQI global score has a possible range of 0-21 points. Any score above 5 is considered insomnia. The higher the score the worse the condition.

Sleep efficiency [ Time Frame: 3 months ]
Complete list of historical versions of study NCT01162317 on ClinicalTrials.gov Archive Site
Wrist Actigraphy (an Objective Sleep Measure) Sleep Efficiency [ Time Frame: pre-intervention, post-intervention (1wk of recording each) ]
Wrist actigraphy is a non-invasive method of continuously monitoring gross body activities when a watch-like actimetry sensor is worn at the non-dominant wrist. An algorithm has been developed to assess sleep/wake behavior. Specifically in this study, we used Respironics® actiwatches for data collection. Subjects were asked to wear the actiwatches for a consecutive week at baseline and then at post-intervention, and the actiwatches were taken off only during showers. Wrist actigraphy was examined in association with sleep diary the subjects were to keep for the weeks of monitoring. Threshold-based method algorithm for data interpretation was provided by Respironics® Actiware Software. Medium level threshold was set to detect Wake and Sleep; sleep interval detection algorithm was set for 3 minutes of immobile minutes for Sleep Onset and 5 minutes of immobile minutes for Sleep End. Sleep efficiency is sleep duration divided by total bed time (both in minutes), times 100%.
Not Provided
Not Provided
Not Provided
 
AcuSleep in Mild Traumatic Brain Injury (TBI)
Novel Approaches to Sleep Difficulties: Application in Mild TBI

Objective: To evaluate real acupuncture, as compare to sham acupuncture, in improving persistent sleep difficulties in veterans with mild traumatic brain injury (mTBI) Design: Randomized, blinded, sham-controlled clinical trial Setting: Outpatient clinic at a major VA medical center in Southeast USA Participants: Sixty veterans aged 24-55 (mean 40) with history of mTBI at least 3-month and beyond, suffering from sleep difficulties refractory to regular care and sleep education, as indicated by a global Pittsburgh Sleep Quality Index (PSQI) score of 14.25 + 3.23 pre-intervention (baseline). They were randomized into 2 groups, real acupuncture versus sham acupuncture, and stratified by Post-traumatic stress disorder (PTSD) diagnosed by PTSD CheckList - Military Version (PCL-M).

Intervention: Real or sham acupuncture with both standardized and individualized acupoints selection. All subjects were informed that the treatments, if effective, may improve symptoms such as pain, anxiety or depression other than sleep; real acupuncture may not be effective in some individuals, and sham acupuncture may as well be effective by mind-body interactions.

Outcome Measures: Primary outcome measure was global PSQI score change after intervention as compared to baseline. Secondary outcome measure was wrist-actigraphy sleep latency, sleep efficiency, wake after sleep onset (WASO), and sleep duration. PTSD was analyzed as a co-variant.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
  • Brain Injuries, Traumatic
  • Sleeplessness
  • Other: Acupuncture
    Treatments will be performed by the PI, who is a licensed physician acupuncturist and has practiced acupuncture independently for 5 years with about 4000 patient/visit treatment history. A total of 10 acupuncture treatments represents a reasonable approach to optimal duration of treatment. Acupoint selection will be based on a combination of standardization and individualization for best treatment effects. At least 5 standardized body and auricular acupoints will be selected. Standardized sterile, disposable acupuncture needles will be applied for 20 minutes.
  • Other: Sham Acupuncture
    Treatments will be performed by the PI, who is a licensed physician acupuncturist and has practiced acupuncture independently for 5 years with about 4000 patient/visit treatment history. A total of 10 acupuncture treatments represent a reasonable approach to optimal duration of treatment. Acupoint selection will be based on a combination of standardization and individualization for best treatment effects. At least 5 standardized body and auricular acupoints will be selected. Standardized sterile, disposable acupuncture needles will be applied for 20 minutes. Each sham or real acupuncture needle will be applied through a tube as sham needles have blunt tip and telescopic shaft, the visual effect and percutaneous sensation of sham needle mimic the real needle penetration.
  • Active Comparator: Arm 1: sham acupuncture
    sham acupuncture
    Intervention: Other: Sham Acupuncture
  • Experimental: Arm 2: acupuncture
    acupuncture
    Intervention: Other: Acupuncture
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
60
December 30, 2017
September 30, 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age: 18 to 55; and,
  • Meeting the diagnosis criteria for mild traumatic brain injury as listed above at the time of injury; and,
  • At or over 3 months post injury; and,
  • With untreated sleep complaints (Pittsburgh Sleep Quality Index [PSQI] > 8, sleep difficulties at least 4x per week in the past month, average sleep duration of 6 hours or less); and,
  • Has the capacity to give informed consent.
  • Agree to attend 13 clinic visits

Exclusion Criteria:

  • Same sleep complaints present prior to traumatic brain injury; or,
  • Diagnosis of obstructive sleep apnea (OSA) by prior sleep study; or,
  • With a non-daytime work-schedule; or,
  • With prior acupuncture experience for the treatment of sleep difficulties or with acupuncture treatment within 3 months; or,
  • History of bleeding diathesis or currently on anticoagulation with international normalized ratio (INR) over 2.5; or,
  • Severe depression with Beck Depression Score of 29 and above; or,
  • Moderate and severe alcohol users.
  • Does not have a permanent address
Sexes Eligible for Study: All
18 Years to 55 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01162317
B6924-W
No
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Plan to Share IPD: No
VA Office of Research and Development
VA Office of Research and Development
Not Provided
Principal Investigator: Wei Huang, MD PhD Atlanta VA Medical and Rehab Center, Decatur, GA
VA Office of Research and Development
July 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP